Study of U3-1402 in EGFR Mutant NSCLC

Pasi A Jänne, MD, Director, Lowe Center for Thoracic Oncology, Belfer Center for Applied Cancer Science, Senior Physician, Professor of Medicine at Harvard Medical School discusses details on the study of U3-1402 in EGFR mutant non-small cell lung cancer (NSCLC).